yep
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge US$2340 ($3400) for a typical treatment course for people covered by government health programs in the United States and other developed countries.Gilead Sciences announced the price on Monday for remdesivir, and said the price would be US$3120 ($4555) for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors."We're in uncharted territory with pricing a new medicine, a novel medicine, in a pandemic," Gilead's chief executive, Dan O'Day, told The Associated Press
- Forums
- ASX - By Stock
- Biotronwave
yepThe maker of a drug shown to shorten recovery time for...
-
- There are more pages in this discussion • 194 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
2.6¢ |
Change
-0.001(3.70%) |
Mkt cap ! $23.46M |
Open | High | Low | Value | Volume |
2.7¢ | 2.7¢ | 2.6¢ | $8.415K | 322.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 37530 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.026 |
8 | 824946 | 0.025 |
2 | 3453333 | 0.024 |
1 | 130000 | 0.023 |
4 | 825000 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 37530 | 1 |
0.028 | 145600 | 2 |
0.029 | 260000 | 2 |
0.030 | 49844 | 3 |
0.031 | 280868 | 5 |
Last trade - 15.23pm 16/08/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |